JULIA GOPSTEIN: Open Payments
NPI 1831728153 · PLAINSBORO, NJ. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,573 in 82 payments from 15 companies in 2025. Trend: 2023 $818 · 2024 $1,206 · 2025 $1,573
Food & beverage: $1,564Education: $10
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 23 | $392 |
| Janssen Biotech, Inc. | 8 | $179 |
| Madrigal Pharmaceuticals | 10 | $158 |
| Ardelyx, Inc. | 7 | $148 |
| GENZYME CORPORATION | 6 | $134 |
| Salix Pharmaceuticals, a division of Bausch Health US, LLC | 6 | $102 |
| Takeda Pharmaceuticals U.S.A., Inc. | 5 | $98 |
| Lilly USA, LLC | 5 | $97 |
| Phathom Pharmaceuticals, Inc. | 5 | $74 |
| Janssen Scientific Affairs, LLC | 1 | $74 |
Products named: RINVOQ, TREMFYA, REZDIFFRA, IBSRELA, DUPIXENT, SKYRIZI, XIFAXAN, OMVOH.
Industry payments across NJ — which companies pay providers there.
